InsiderTrades.com logo

SKYE Insider Trading

Insider Ownership Percentage: 4.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,601,097.00

Skye Bioscience Insider Trading History Chart

This chart shows the insider buying and selling history at Skye Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Skye Bioscience Share Price & Price History

Current Price: $1.21
Price Change: ▼ Price Decrease of -0.01 (-0.82%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for SKYE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Skye Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/20255Am Partners Vii, LlcMajor ShareholderSell170,449$3.42$582,935.5857,493View SEC Filing Icon  
8/22/2025Andrew J SchwabDirectorSell170,449$3.42$582,935.5857,493View SEC Filing Icon  
8/21/20255Am Partners Vii, LlcMajor ShareholderSell60,956$3.57$217,612.9263,963View SEC Filing Icon  
8/21/2025Andrew J SchwabDirectorSell60,956$3.57$217,612.9263,963View SEC Filing Icon  
11/18/2024Kaitlyn ArsenaultCFOSell43,206$4.99$215,597.94166,342View SEC Filing Icon  
11/18/2024Paul A GraysonDirectorSell86,244$4.99$430,357.56259,701View SEC Filing Icon  
11/18/2024Punit DhillonCEOSell82,546$4.99$411,904.54329,823View SEC Filing Icon  
11/18/2024Tuan Tu DiepInsiderSell19,489$4.99$97,250.1182,259View SEC Filing Icon  
11/15/2024Kaitlyn ArsenaultCFOSell190$5.55$1,054.50209,548View SEC Filing Icon  
11/15/2024Paul A GraysonDirectorSell307$5.55$1,703.85345,945View SEC Filing Icon  
11/15/2024Punit DhillonCEOSell364$5.55$2,020.20412,369View SEC Filing Icon  
11/15/2024Tuan Tu DiepInsiderSell85$5.55$471.75101,748View SEC Filing Icon  
9/13/2024Andrew J SchwabDirectorSell13,837$6.06$83,852.2266,277View SEC Filing Icon  
9/11/2024Andrew J SchwabDirectorSell252,500$6.60$1,666,500.0066,356View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Skye Bioscience (NASDAQ:SKYE)

21.09% of Skye Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SKYE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Skye Bioscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Qube Research & Technologies Ltd16,658$65K0.0%-68.1%0.052%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.269,734$1.06M0.0%-7.0%0.841%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP92,318$0.36M0.0%+46.2%0.288%Search for SEC Filing on Google Icon
11/13/2025Platinum Investment Management Ltd.233,095$0.92M0.1%-20.5%0.727%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP13,397$53K0.0%N/A0.043%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.882,785$3.47M0.0%+5.3%2.849%Search for SEC Filing on Google Icon
10/21/2025Capital Advisors Inc. OK10,000$39K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 10,927$46K0.0%+121.3%0.035%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.289,979$1.21M0.0%-6.5%0.936%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd52,204$0.22M0.0%N/A0.168%Search for SEC Filing on Google Icon
8/13/2025Capital Advisors Wealth Management LLC50,800$0.21M0.0%+143.1%0.164%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP104,347$0.44M0.0%N/A0.337%Search for SEC Filing on Google Icon
8/13/2025Millington Financial Advisors LLC10,000$44K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC201,921$0.84M0.0%-54.2%0.652%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd10,046$42K0.0%N/A0.032%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.310,013$0.49M0.0%-5.0%1.001%Search for SEC Filing on Google Icon
5/15/2025Driehaus Capital Management LLC620,395$0.99M0.0%-4.7%2.003%Search for SEC Filing on Google Icon
5/13/2025Altium Capital Management LLC904,865$1.44M3.5%-20.6%2.921%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC23,389$37K0.0%N/A0.076%Search for SEC Filing on Google Icon
4/25/2025Capital Advisors Wealth Management LLC20,900$33K0.0%N/A0.067%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC13,546$38K0.0%N/A0.045%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP11,200$32K0.0%N/A0.037%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.326,241$0.92M0.0%-5.3%1.075%Search for SEC Filing on Google Icon
2/17/2025Ensign Peak Advisors Inc767,287$2.17M0.0%-14.7%2.529%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG40,835$0.12M0.0%+365.0%0.135%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC72,000$0.20M0.0%+26.3%0.237%Search for SEC Filing on Google Icon
2/17/2025Braidwell LP825,732$2.34M0.1%N/A2.722%Search for SEC Filing on Google Icon
2/17/2025Baker BROS. Advisors LP1,450,638$4.11M0.0%+1.1%4.781%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE39,257$0.11M0.0%+37.4%0.129%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets31,637$90K0.0%-33.3%0.104%Search for SEC Filing on Google Icon
2/17/2025Alyeska Investment Group L.P.456,163$1.29M0.0%-17.7%1.504%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC36,057$0.10M0.0%+195.5%0.119%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC1,422,741$4.03M0.0%+48.3%4.689%Search for SEC Filing on Google Icon
2/14/2025AdvisorShares Investments LLC88,391$0.25M0.0%-23.1%0.291%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp135,712$0.38M0.0%-3.7%0.447%Search for SEC Filing on Google Icon
2/14/2025Altium Capital Management LLC1,139,000$3.22M0.9%-13.4%3.754%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC69,620$0.20M0.0%+20.3%0.229%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN11,199$32K0.0%+49.0%0.037%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC405,694$1.15M0.0%+5.2%1.337%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC10,142$29K0.0%N/A0.033%Search for SEC Filing on Google Icon
2/11/2025Platinum Investment Management Ltd.434,046$1.23M0.1%-10.5%1.431%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.62,363$0.18M0.0%+20.7%0.206%Search for SEC Filing on Google Icon
1/1/2025JPMorgan Chase & Co.11,362$44K0.0%-24.1%0.037%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC57,889$0.23M0.0%+36.7%0.191%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC385,793$1.51M0.0%+4.2%1.272%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC57,889$0.23M0.0%+36.7%0.191%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC12,200$48K0.0%N/A0.040%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.1,563,522$6.11M1.0%+20.4%5.153%Search for SEC Filing on Google Icon
11/15/2024State Street Corp354,205$1.39M0.0%+7.0%1.167%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.416,424$1.63M0.0%-25.6%1.373%Search for SEC Filing on Google Icon
11/15/2024Baker BROS. Advisors LP1,434,634$5.61M0.1%+186.9%4.729%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets47,417$0.19M0.0%+71.1%0.156%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd6,000$48K0.0%N/A0.021%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.27,768$0.22M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.560,000$4.49M0.0%N/A1.995%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC500,000$4.01M0.1%N/A1.781%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC650,758$5.21M0.0%N/A2.319%Search for SEC Filing on Google Icon
8/15/2024CVI Holdings LLC679,739$5.45M4.9%N/A2.422%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.27,768$0.22M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd6,000$48K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP1,301,518$10.43M0.8%N/A4.637%Search for SEC Filing on Google Icon
8/8/2024AdvisorShares Investments LLC26,000$0.21M0.0%N/A0.093%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers19,754$0.16M0.0%N/A0.070%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp58,778$0.47M0.0%N/A0.209%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Skye Bioscience logo
Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.
Read More on Skye Bioscience

Today's Range

Now: $1.21
Low: $1.18
High: $1.24

50 Day Range

MA: $1.78
Low: $1.11
High: $4.75

52 Week Range

Now: $1.21
Low: $1.10
High: $5.75

Volume

164,982 shs

Average Volume

288,853 shs

Market Capitalization

$38.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.68

Who are the company insiders with the largest holdings of Skye Bioscience?

Skye Bioscience's top insider shareholders include:
  1. Punit Dhillon (CEO)
  2. Paul A Grayson (Director)
  3. Kaitlyn Arsenault (CFO)
  4. Tuan Tu Diep (Insider)
  5. Andrew J Schwab (Director)
  6. 5Am Partners Vii, Llc (Major Shareholder)
Learn More about top insider investors at Skye Bioscience.

Who are the major institutional investors of Skye Bioscience?

Skye Bioscience's top institutional investors include:
  1. Vanguard Group Inc. — 2.85%
  2. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. — 0.84%
  3. Platinum Investment Management Ltd. — 0.73%
  4. Two Sigma Investments LP — 0.29%
  5. Susquehanna International Group LLP — 0.00%
  6. Qube Research & Technologies Ltd — 0.05%
Learn More about top institutional investors of Skye Bioscience stock.

Which institutional investors are selling Skye Bioscience stock?

In the last quarter, SKYE stock was sold by these institutional investors:
  1. Platinum Investment Management Ltd.
  2. Qube Research & Technologies Ltd
  3. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
  4. Susquehanna International Group LLP
During the previous year, company insiders that have sold Skye Bioscience company stock include:
  1. Punit Dhillon (CEO)
  2. Paul A Grayson (Director)
Learn More investors selling Skye Bioscience stock.

Which institutional investors are buying Skye Bioscience stock?

In the previous quarter, SKYE stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Two Sigma Investments LP
  3. Dimensional Fund Advisors LP
  4. Capital Advisors Inc. OK
  5. Group One Trading LLC